Report of AAPM Task Group 219 on independent calculation‐based dose/MU verification for IMRT

Citations Over TimeTop 1% of 2021 papers

Abstract

Independent verification of the dose per monitor unit (MU) to deliver the prescribed dose to a patient has been a mainstay of radiation oncology quality assurance (QA). We discuss the role of secondary dose/MU calculation programs as part of a comprehensive QA program. This report provides guidelines on calculation-based dose/MU verification for intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT) provided by various modalities. We provide a review of various algorithms for "independent/second check" of monitor unit calculations for IMRT/VMAT. The report makes recommendations on the clinical implementation of secondary dose/MU calculation programs; on commissioning and acceptance of various commercially available secondary dose/MU calculation programs; on benchmark QA and periodic QA; and on clinically reasonable action levels for agreement of secondary dose/MU calculation programs.

Related Papers

• → Task Group 142 report: Quality assurance of medical acceleratorsa)(2009)1,566 cited
• → Report of AAPM Task Group 235 Radiochromic Film Dosimetry: An Update to TG‐55(2020)311 cited
• → Practical application of AAPM Report 270 in display quality assurance: A report of Task Group 270(2020)18 cited
• → WE‐B‐BRA‐01: TG‐142: Quality Assurance for Medical Accelerators(2011)3 cited
• → TU-B-203-01: QA of Radiation Delivery Systems: TG-142 Quality Assurance of Medical Accelerators(2010)2 cited